Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 11Thoracic 7Gastrointestinal 7Other solid neoplasm 6Lymphoid 4Gynecologic 4Genitourinary 3CNS 3Tumor-Agnostic 2Other hematologic neoplasm 2Sarcoma 1Head & Neck 1

Conditions

Prostatic Neoplasms 1Non Castrate Metastatic Prostate Cancer 1Neoplasm Metastasis 1Castration-resistant Prostate Cancer 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × NVP-BKM120 × Genitourinary × Clear all
NCT01634061 2020-12-09

Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

Novartis

Phase 1 Completed
43 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT01741753 2019-02-05

BKM120+Abiraterone Acetate for Metastatic CRPC

Dana-Farber Cancer Institute

Phase 1 Terminated
4 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02487823 2017-11-17

NCMPC-BKM

Institut Paoli-Calmettes

Phase 1 Terminated
6 enrolled
Genitourinary

Non Castrate Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡